1. Home
  2. WULF vs CYTK Comparison

WULF vs CYTK Comparison

Compare WULF & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WULF
  • CYTK
  • Stock Information
  • Founded
  • WULF 1952
  • CYTK 1997
  • Country
  • WULF United States
  • CYTK United States
  • Employees
  • WULF N/A
  • CYTK N/A
  • Industry
  • WULF EDP Services
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • WULF Technology
  • CYTK Health Care
  • Exchange
  • WULF Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • WULF 4.5B
  • CYTK 4.6B
  • IPO Year
  • WULF 1995
  • CYTK 2004
  • Fundamental
  • Price
  • WULF $16.06
  • CYTK $60.01
  • Analyst Decision
  • WULF Strong Buy
  • CYTK Strong Buy
  • Analyst Count
  • WULF 12
  • CYTK 15
  • Target Price
  • WULF $15.96
  • CYTK $76.73
  • AVG Volume (30 Days)
  • WULF 46.4M
  • CYTK 1.7M
  • Earning Date
  • WULF 11-10-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • WULF N/A
  • CYTK N/A
  • EPS Growth
  • WULF N/A
  • CYTK N/A
  • EPS
  • WULF N/A
  • CYTK N/A
  • Revenue
  • WULF $144,085,000.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • WULF $47.62
  • CYTK $363.61
  • Revenue Next Year
  • WULF $102.57
  • CYTK $64.08
  • P/E Ratio
  • WULF N/A
  • CYTK N/A
  • Revenue Growth
  • WULF 19.82
  • CYTK 2635.74
  • 52 Week Low
  • WULF $2.06
  • CYTK $29.31
  • 52 Week High
  • WULF $17.05
  • CYTK $64.13
  • Technical
  • Relative Strength Index (RSI)
  • WULF 66.42
  • CYTK 55.45
  • Support Level
  • WULF $14.01
  • CYTK $54.30
  • Resistance Level
  • WULF $17.05
  • CYTK $64.13
  • Average True Range (ATR)
  • WULF 1.34
  • CYTK 2.81
  • MACD
  • WULF 0.08
  • CYTK -0.18
  • Stochastic Oscillator
  • WULF 81.22
  • CYTK 58.09

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: